We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Uscom is a medical devices business based in Australia. Uscom shares (UCM) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Uscom has a trailing 12-month revenue of around $4.6 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Long-term investing
| 52-week range | $0.1 - $0.18 |
|---|---|
| 50-day moving average | $0.1141 |
| 200-day moving average | $0.1401 |
| Target price | $0.3 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.006 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.11
| 1 week (2022-01-11) | 4.76% |
|---|---|
| 1 month (2021-12-17) | 0.11 |
| 3 months (2021-10-19) | -21.43% |
| 6 months (2021-07-19) | -31.25% |
| 1 year (2021-01-19) | -31.25% |
|---|---|
| 2 years (2020-01-17) | -21.43% |
| 3 years (2019-01-15) | -21.43% |
| 5 years (2017-01-18) | -58.49% |
Valuing Uscom stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Uscom 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Uscom 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $486,040 (£256,912).
The EBITDA is a measure of a Uscom 's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.6 million |
|---|---|
| Gross profit TTM | $4.1 million |
| Return on assets TTM | -8.74% |
| Return on equity TTM | -28.44% |
| Profit margin | -20.29% |
| Book value | 0.02 |
| Market capitalisation | $20.6 million |
TTM: trailing 12 months
We're not expecting Uscom to pay a dividend over the next 12 months.
Over the last 12 months, Uscom 's shares have ranged in value from as little as $0.1 up to $0.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Uscom 's is -1.132. This would suggest that Uscom 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Uscom has bucked the trend.
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company provides the SpiroSonic AIR, a digital home care spirometer which feeds digital lung function signals through a phone app; and Ventitest, a digital ultrasonic ventilator testing solution for testing ventilators. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.
Here's where you can book COVID-19 at-home tests approved for travel and how they work.
We've rounded up everything you need to nail the 'date-worthy' makeup look, including some affordable dupes.
Designed for big companies, this Amex charge card offers a mix of management tools and perks – including a 100,000 bonus Membership Rewards offer.
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
We tried the viral Milk Makeup Hydro Grip Primer and spoiler alert, it's the bee's knees.
Drac and the Pack are back, like you’ve never seen them before.
A delightful compact vacuum with an unjustifiable price.
A new player enters the Australian sports broadcast market.
The Amazon Echo Buds 2 are a solid addition to your earholes if you’re already integrated in the Alexa ecosystem. But if you’re not, its hard to find anything here that really stands out.
Bottom meets top in the BBL as Perth look to continue their winning ways against the Strikers.
